Company News in the Life Science Industry

»

Reset 

BioSpace Life Sciences Compensation Report Finds Growing Salaries but a Wide Gender Gap

DES MOINES, Iowa, July 22, 2019 /PRNewswire/ -- According to a new report by BioSpace, the life science leader in news and careers, more than 65% of life science professionals received a salary increase in the last year with the average increase being 4.4%. The findings place the average industry... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  BioSpace, Inc.

Neogen awarded USDA contract

LANSING, Mich., July 22, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it had again been awarded the contract to supply certain dehydrated culture media to the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS).

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  Neogen Corporation

CannTrust Special Committee Update

VAUGHAN, ON, July 22, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019

Chemistree Completes Investment in New Jersey Cannabis Applicant - ACS

VANCOUVER, July 22, 2019 /CNW/ - Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that through a wholly owned U.S. subsidiary, the Company has finalized its investment into Applied Cannabis Sciences of New Jersey ("ACS"), a New Jersey-based... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019

CRH Medical Corporation Announces Majority Purchase of Crystal River Anesthesia

VANCOUVER, July 22, 2019 /CNW/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE MKT: CRHM), announces that it has completed an accretive transaction whereby the Company has acquired a 51% interest in Crystal River Anesthesia Associates, LLC, ("Crystal River") a gastroenterology... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  CRH Medical Corporation

PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  PCI Biotech Holding ASA

Saniona selects highly promising preclinical candidate with broad potential in autoimmune disorders

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019

Aino Health AB (publ): Aino Health Germany signs partnership agreement with 55BirchStreet

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Aino Health AB (publ)

Orion Corporation: Managers’ transactions – Timo Lappalainen

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Orion Corporation

Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Adynxx, Inc.

Transactions under Novozymes’ stock buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Novozymes A/S

fishbat Explains What to Do If Your Clinical Trial Goes Global

NEW YORK, July 22, 2019 /PRNewswire/ -- Globalization has had a definitive impact on nearly every industry, and, in recent years, its effects on the clinical trials industry have become apparent. Clinical trials are necessary for public health in every society, developed and developing alike,... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019

Innovative geko™ Technology Recognised With Nomination at National Awards

HIGH WYCOMBE, England, July 22, 2019 /PRNewswire/ -- Sky Medical Technology (Sky) has been recognised for its innovative potential to solve healthcare's most pressing challenges. Its pioneering neuromuscular stimulation device, the geko™, has seen the company secure a recent nomination at the... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019

DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019

DENVER, July 22, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita" or "Company"), today announced preliminary second quarter 2019 financial and operating results and updated guidance for fiscal year 2019.

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  DaVita Inc.

SVS: Is Thoracic Outlet Syndrome More Common Or Just Better Understood?

ROSEMONT, Ill., July 22, 2019 /PRNewswire/ -- Hardly a sports season goes by without at least one professional player going on the injured list for thoracic outlet syndrome, also called TOS.

Read more ››
By: PR Newswire Association LLC. - 22 Jul 2019

Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Philips delivers Q2 sales of EUR 4.7 billion, with 6% comparable sales growth and 8% comparable order intake growth; income from continuing operations increases to EUR 260 million and Adjusted EBITA margin improves to 11.8%

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019

The WHO Recognizes NOX Inhibitors as New Therapeutic Class and Approves Setanaxib for GKT831

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Genkyotex S.A.

CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML

SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  CStone Pharmaceuticals

Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center

SYDNEY, July 22, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) in New York, NY will investigate the potential use of Kazia's investigational... Read more ››

By: PR Newswire Association LLC. - 22 Jul 2019
Related companies:  Memorial Sloan Kettering Cancer Center
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies